Seeing Is Believing
ONCT is currently covered by 5 analysts with an average price target of $9.91. This is a potential upside of $1.36 (15.91%) from yesterday's end of day stock price of $8.55.
Oncternal Therapeutics's activity chart (see below) currently has 0 price targets and 14 ratings on display. The stock rating distribution of ONCT is 64.29% BUY and 35.71% HOLD.
Analysts average stock forecasts to be materialized ratio is 48% with an average time for these price targets to be met of 150 days.
Highest price target for ONCT is $28, Lowest price target is $1.3, average price target is $9.91.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 15-Apr-2024. First documented stock forecast 10-May-2022.
Currently out of the existing stock ratings of ONCT, 9 are a BUY (64.29%), 5 are a HOLD (35.71%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
28
$19.45 (227.49%)
30
9 days ago
2/5 (40%)
$19.2 (218.18%)
129
Buy
2
$-6.55 (-76.61%)
4 months 20 days ago
0/1 (0%)
$-5 (-71.43%)
Hold
1.3
$-7.25 (-84.80%)
4
7 months 17 days ago
0/3 (0%)
$-4.7 (-78.33%)
Hold
9
1 years 20 days ago
1/1 (100%)
$-5.2 (-36.62%)
13
Hold
3.5
1 years 21 days ago
1/1 (100%)
$2.5 (250.00%)
608
What is ONCT (Oncternal Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ONCT (Oncternal Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ONCT (Oncternal Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ONCT (Oncternal Therapeutics)?
Which analyst is the currently most bullish on ONCT (Oncternal Therapeutics)?
Which analyst is the currently most reserved on ONCT (Oncternal Therapeutics)?